Cavillon A, Pouessel D, Houede N, Mathevet F, et al. Assessing Long-term Treatment Benefits Using Complementary Statistical Approaches: An In Silico Analysis of the Phase III Keynote-045 and Checkmate-214 Immune Checkpoint Inhibitor Trials. Eur Urol 2024;85:293-300.
PMID: 36849297